|
|
|
|
Drug Interactions and Side Effects of Lantus  Lantus has 11 Side Effects total
8 are Life Threatening
1 Occur Most Frequently
Uses of Lantus |
|---|
| | Lantus is also known by the generic name Insulin Glargine
USES:
Insulin glargine is used along with a proper diet and exercise program to control high blood sugar. It is used in people with type 1 (insulin-dependent) or type 2 (non-insulin-dependent) diabetes. Insulin glargine is a man-made, long-acting type of insulin that is similar to human insulin. It starts working more slowly and lasts for a longer time than regular insulin.
Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.
|
Lantus has 8 Life Threatening (Critical) Side Effects |
|---|
| | Critical Seriousness - Abnormally Low Blood Pressure - Hypotension is a Life Threatening Side Effect of Lantus Critical Seriousness - Excessive Sweating - Hyperhidrosis is a Life Threatening Side Effect of Lantus Critical Seriousness - Fast Heartbeat - Tachyarrhythmia is a Life Threatening Side Effect of Lantus Critical Seriousness - Itching - Pruritus of Skin is a Life Threatening Side Effect of Lantus Critical Seriousness - Low Blood Sugar - Hypoglycemic Disorder is a Life Threatening Side Effect of Lantus Critical Seriousness - Rash - Skin Rash is a Life Threatening Side Effect of Lantus Critical Seriousness - Trouble Breathing - Dyspnea is a Life Threatening Side Effect of Lantus Critical Seriousness - Wheezing is a Life Threatening Side Effect of Lantus |
Lantus has 1 Most Frequently Occurring Side Effects |
|---|
| | Low Blood Sugar - Hypoglycemic Disorder is a Frequently Occurring Side Effect of Lantus |
Lantus Drug-Drug Interactions |
|---|
| | Lantus has interactions of severe seriousness with 0 drug(s):
Lantus has interactions of serious seriousness with 20 drug(s).
Lantus has interactions of moderate seriousness with 491 drug(s).
Lantus has interactions of unknown seriousness with 160 drug(s).
|
Lantus has 11 Condition Contraindications |
|---|
| | If you have any of these Conditions then you should carefully evaluate the risks of taking Lantus.
Lantus Subcutaneous Contraindications
(grouped by decreasing seriouosness level)
Relative Contraindications 
Hypoglycemic Disorder - Low Blood Sugar is a contraindication of Lantus.
Hypokalemia - Low Amount of Potassium in the Blood is a contraindication of Lantus.
Contraindication Warnings
Celiac Disease - Failure of Small Intestines to Digest and Absorb Food is a contraindication of Lantus.
Disease of Liver - Liver Problems is a contraindication of Lantus.
Eating Disorders - Eating Disorder is a contraindication of Lantus.
High Fever >101 Degrees Fahrenheit - Body Temperature More Than 101 Degrees F is a contraindication of Lantus.
Hyperthyroidism - Overactive Thyroid Gland is a contraindication of Lantus.
Hypothyroidism - Underactive Thyroid is a contraindication of Lantus.
Renal Disease - Kidney Disease is a contraindication of Lantus.
Trauma - Injury is a contraindication of Lantus.
Vomiting - Throwing Up is a contraindication of Lantus. |
Lantus has 6 related brands and strengths: |
|---|
| | Insulin Glargine 100 Unit/Ml (3 Ml) Sub-Q Pen
Insulin Glargine 100 Unit/Ml Sub-Q
Insulin Glargine 100 Unit/Ml Subq Cartridge
Lantus 100 Unit/Ml Sub-Q
Lantus 100 Unit/Ml Subq Cartridge
Lantus Solostar 100 Unit/Ml (3 Ml) Sub-Q Insulin Pen
|
Lantus - Symptoms of overdose may include
very fast heartbeat, vision changes, unexplained heavy sweating, agitation, fainting, seizures.
Contact poison control
If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly.
|
|
|